IRIS

The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the treatment of many urologic cancers. Patients and clinicians should consider the oncologic risk of delayed cancer intervention versus the risks of COVID-19 to patients, treating health care professionals, and the health care system.

Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic[Formula presented]

Necchi A.;
2020-01-01

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the treatment of many urologic cancers. Patients and clinicians should consider the oncologic risk of delayed cancer intervention versus the risks of COVID-19 to patients, treating health care professionals, and the health care system.
2020
Inglese
Elsevier B.V.
78
1
29
42
14
Pubblicato
2-s2.0-85085123507
WOS:000543901000019
Bladder cancer
Coronavirus
Coronavirus disease 2019
Delayed treatment
Kidney cancer
Penile cancer
Prostate cancer
Sstemic therapy
Surgery
Testicular cancer
Upper tract urothelial carcinoma
COVID-19
Combined Modality Therapy
Coronavirus Infections
Humans
Pneumonia, Viral
Risk Factors
SARS-CoV-2
Time-to-Treatment
Triage
Urogenital Neoplasms
Betacoronavirus
Disease Management
Pandemics
none
15
info:eu-repo/semantics/article
262
Wallis, C. J. D.; Novara, G.; Marandino, L.; Bex, A.; Kamat, A. M.; Karnes, R. J.; Morgan, T. M.; Mottet, N.; Gillessen, S.; Bossi, A.; Roupret, M.; P...espandi
1 Contributo su Rivista::1.1.3. Articolo in Rivista - Editorial, Comment, Reply
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/110066
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 113
  • ???jsp.display-item.citation.isi??? 104
social impact